Search Press releases Keywords From To 6 Feb 2024 Transparency notification FMR LLC Read More 8 Jan 2024 UCB announces European Commission approval of RYSTIGGO[®]▼ (rozanolixizumab) for the treatment of adults with generalized myasthenia gravis in Europe Read More 27 Dec 2023 BIMZELX® (bimekizumab) Receives Approval in Japan for the Treatment of Psoriatic Arthritis, Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Read More 4 Dec 2023 UCB announces European Commission approval of ZILBRYSQ[®]▼ (zilucoplan) for the treatment of adults with generalized Myasthenia Gravis Read More 1 Dec 2023 UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting Read More 23 Nov 2023 Transparency notification Wellington Read More Pagination First page Previous page Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
